Literature DB >> 19640930

NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse.

Gilles Kauffenstein1, Annick Drouin, Nathalie Thorin-Trescases, Hélène Bachelard, Bernard Robaye, Pedro D'Orléans-Juste, François Marceau, Eric Thorin, Jean Sévigny.   

Abstract

AIMS: Extracellular nucleotides are vasoactive molecules. The concentrations of these molecules are regulated by ectonucleotidases. In this study, we investigated the role of the blood vessel ectonucleotidase NTPDase1, in the vasoconstrictor effect of nucleotides using Entpd1(-/-) mice. METHODS AND
RESULTS: Immunofluorescence, enzyme histochemistry, and HPLC analysis were used to evaluate both NTPDase expression and activity in arteries and isolated vascular smooth muscle cells (VSMCs). Vascular reactivity was evaluated in vitro and mean arterial blood pressure was recorded in anesthetized mice after nucleotide i.v. infusion. Expression of nucleotide receptors in VSMCs was determined by RT-PCR. Entpd1(-/-) mice displayed a dramatic deficit of nucleotidase activity in blood vessel wall in situ and in VSMCs in comparison to control mice. In aortic rings from Entpd1(-/-) mice, UDP and UTP induced a potent and long-lasting constriction contrasting with the weak response obtained in wild-type rings. This constriction occurred through activation of P2Y(6) receptor and was independent of other uracil nucleotide-responding receptors (P2Y(2) and P2Y(4)). UDP infusion in vivo increased blood pressure and this effect was potentiated in Entpd1(-/-) mice. In addition, pressurized mesenteric arteries from Entpd1(-/-) mice displayed an enhanced myogenic response, consistent with higher local concentrations of endogenously released nucleotides. This effect was inhibited by the P2 receptor antagonist RB-2.
CONCLUSION: NTPDase1 is the major enzyme regulating nucleotide metabolism at the surface of VSMCs and thus contributes to the local regulation of vascular tone by nucleotides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19640930      PMCID: PMC3694873          DOI: 10.1093/cvr/cvp265

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  50 in total

Review 1.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.

Authors:  Eduardo R Lazarowski; Richard C Boucher; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2003-10       Impact factor: 4.436

Review 2.  Pathophysiology and therapeutic potential of purinergic signaling.

Authors:  Geoffrey Burnstock
Journal:  Pharmacol Rev       Date:  2006-03       Impact factor: 25.468

3.  Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice.

Authors:  Kimiko Yamamoto; Takaaki Sokabe; Takahiro Matsumoto; Kimihiro Yoshimura; Masahiro Shibata; Norihiko Ohura; Toru Fukuda; Takashi Sato; Keisuke Sekine; Shigeaki Kato; Masashi Isshiki; Toshiro Fujita; Mikio Kobayashi; Koichi Kawamura; Hirotake Masuda; Akira Kamiya; Joji Ando
Journal:  Nat Med       Date:  2005-12-04       Impact factor: 53.440

4.  Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.

Authors:  Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

5.  Disordered cellular migration and angiogenesis in cd39-null mice.

Authors:  C Goepfert; C Sundberg; J Sévigny; K Enjyoji; T Hoshi; E Csizmadia; S Robson
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

6.  Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells.

Authors:  P Heine; N Braun; A Heilbronn; H Zimmermann
Journal:  Eur J Biochem       Date:  1999-05

7.  CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness.

Authors:  Norikatsu Mizumoto; Tadashi Kumamoto; Simon C Robson; Jean Sévigny; Hiroyuki Matsue; Keiichi Enjyoji; Akira Takashima
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain.

Authors:  N Braun; J Sévigny; S C Robson; K Enjyoji; O Guckelberger; K Hammer; F Di Virgilio; H Zimmermann
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

9.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

10.  Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.

Authors:  I von Kügelgen; D Häussinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

View more
  46 in total

1.  High expression and activity of ecto-5'-nucleotidase/CD73 in the male murine reproductive tract.

Authors:  Mireia Martín-Satué; Elise G Lavoie; Michel Fausther; Joanna Lecka; Elisabet Aliagas; Filip Kukulski; Jean Sévigny
Journal:  Histochem Cell Biol       Date:  2010-05-11       Impact factor: 4.304

2.  Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2011-09-14       Impact factor: 7.658

3.  Expression of pannexin isoforms in the systemic murine arterial network.

Authors:  Alexander W Lohman; Marie Billaud; Adam C Straub; Scott R Johnstone; Angela K Best; Monica Lee; Kevin Barr; Silvia Penuela; Dale W Laird; Brant E Isakson
Journal:  J Vasc Res       Date:  2012-06-26       Impact factor: 1.934

4.  Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.

Authors:  Zachary M Huttinger; Michael W Milks; Michael S Nickoli; William L Aurand; Lawrence C Long; Debra G Wheeler; Karen M Dwyer; Anthony J F d'Apice; Simon C Robson; Peter J Cowan; Richard J Gumina
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

Review 5.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

Review 6.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

7.  NTPDase1 governs P2X7-dependent functions in murine macrophages.

Authors:  Sébastien A Lévesque; Filip Kukulski; Keiichi Enjyoji; Simon C Robson; Jean Sévigny
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

8.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 9.  Pannexin 1 in the regulation of vascular tone.

Authors:  Marie Billaud; Joanna K Sandilos; Brant E Isakson
Journal:  Trends Cardiovasc Med       Date:  2012-07-28       Impact factor: 6.677

10.  TRPM4 channels couple purinergic receptor mechanoactivation and myogenic tone development in cerebral parenchymal arterioles.

Authors:  Yao Li; Rachael L Baylie; Matthew J Tavares; Joseph E Brayden
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.